Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Machine intelligence can be used to improve brain-mapping technique

Machine intelligence can be used to improve brain-mapping technique

Innovative gene therapy approach for regeneration of functional new neurons

Innovative gene therapy approach for regeneration of functional new neurons

ECSIT protein can shed light on the origin of Alzheimer's disease

ECSIT protein can shed light on the origin of Alzheimer's disease

Microglia surveillance helps prevent seizure activity in the brain

Microglia surveillance helps prevent seizure activity in the brain

Study sheds light on molecular underpinnings of long-term memory

Study sheds light on molecular underpinnings of long-term memory

Researchers develop a diagnostic tool for amyotrophic lateral sclerosis

Researchers develop a diagnostic tool for amyotrophic lateral sclerosis

Scientists use advanced methods for investigating structure and interactions of proteins

Scientists use advanced methods for investigating structure and interactions of proteins

Tau protein in Alzheimer's disease looks different at every dementia stage

Tau protein in Alzheimer's disease looks different at every dementia stage

Study confirms correlation between gut microbiota and Alzheimer's disease

Study confirms correlation between gut microbiota and Alzheimer's disease

Researcher develops procedures for defining preclinical stages of Alzheimer's disease

Researcher develops procedures for defining preclinical stages of Alzheimer's disease

Low levels of hydrogen peroxide can slow down cell aging

Low levels of hydrogen peroxide can slow down cell aging

Nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases

Nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases

Genetically edited form of herpes simplex virus outperforms key vaccine candidate

Genetically edited form of herpes simplex virus outperforms key vaccine candidate

LipiDiDiet project shows positive effects of nutrient intervention in early Alzheimer’s disease

LipiDiDiet project shows positive effects of nutrient intervention in early Alzheimer’s disease

Research projects receive BTCA awards to develop new drugs

Research projects receive BTCA awards to develop new drugs

Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's disease

Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's disease

Metabolite of dietary soy may decrease key risk factor for dementia

Metabolite of dietary soy may decrease key risk factor for dementia

Researchers uncover a new cellular mechanism for disposing of misfolded proteins

Researchers uncover a new cellular mechanism for disposing of misfolded proteins

Enzyme SSH1 impairs disposal of damaged tau and mitochondria leaking toxins

Enzyme SSH1 impairs disposal of damaged tau and mitochondria leaking toxins

Researchers discover how synapses find energy to support intense neural conversations

Researchers discover how synapses find energy to support intense neural conversations